You'd have to go to the Make a Wish Foundation if you want to see $5 now. I believe $3-$4 is achievable once we start seeing positive data from the P3 trials. I haven't a clue what our upside could be with good news Monday. It can't hurt. $3 qualifies us for an uplisting and that should be a good enough beginning. The company needs intitutional investors to maintain any substantial gains. Within 5 years the company has a good shot to be in the hands of a BP company and those who are patient enough to hold on could be sitting pretty. Besides making a tidy profit I think the feeling of seeing PRO140 on the market making a big impact on those burdened with HIV will trump even a 5000% return. At least that's how I feel. I own a few early stage immunoncology companies and look forward to their treatment changing the way cancer patients are treated. They may not ever find a cure for cancer but to be able to make cancer a manageable disease and add a full lifetime to those patients will be absolutely amazing.
Market Data 
Markets 
